Skip to main content
Clinical Trials/NCT05097183
NCT05097183
Recruiting
N/A

Clinical Validation and Prognostic Evaluation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation

Ignacio J. Amat Santos15 sites in 1 country274 target enrollmentDecember 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Severe Aortic Valve Stenosis
Sponsor
Ignacio J. Amat Santos
Enrollment
274
Locations
15
Primary Endpoint
Degree of commissural alignment
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

Background: Transcatheter aortic valve replacement (TAVR) has become the preferred therapy for aortic stenosis. Given the growing life-expectancy, the risk of requiring coronary interventions or of developing prosthesis degeneration that could require TAVR-in-TAVR for its treatment progressively increases. During standard TAVI procedures the native and the prosthesis commissures are randomly aligned with misalignment in up to 70% of the cases. This might hinder coronary re-access in 18% of the cases, increase the risk of coronary obstruction during future TAVR-in-TAVR procedures, and has been associated to greater residual gradients.

Methods: Although several techniques have been developed to increase the degree of commissural alignment, all are imperfect or imply manipulation of the system within the patient, potentially increasing the risk of complications. The research team developed a software based on computed tomography analysis that allows planification of accurate commissural alignment by inserting the delivery system in a patient-specific degree of rotation.

Aim: The proponent team aimed to prospectively validate this methodology comparing a cohort of patients harboring TAVR with Acurate Commissural Alignment (ACA) vs. a control cohort with non-ACA standard technique, in order to determine benefits in terms of coronary re-access and clinical events (coronary events, valve degeneration, and TAVR-in-TAVR).

Registry
clinicaltrials.gov
Start Date
December 1, 2021
End Date
December 31, 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Ignacio J. Amat Santos
Responsible Party
Sponsor Investigator
Principal Investigator

Ignacio J. Amat Santos

Coordinator of Interventional Cardiology Unit

Hospital Clínico Universitario de Valladolid

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with severe aortic stenosis admitted to TAVR by Heart Team
  • Pre-procedure CT-Scan for planning available.
  • Signed informed consent.

Exclusion Criteria

  • Allergic to contrast
  • Severe renal failure (GFR \< 30 mL/min)
  • Indication for chronic anticoagulation
  • Horizontal aorta and/or severe aortic tortuosity

Outcomes

Primary Outcomes

Degree of commissural alignment

Time Frame: 6 months

Mean minimum angular deviation between TAVR posts and aortic valve commissures measured in CT-scan

Successful coronary re-access

Time Frame: 10 minutes, right after TAVR

Coronary re-access was successful or not after TAVR implant

Presence of leaflet thrombosis

Time Frame: 6 months

Presence of clinical/subclinical leaflets thrombosis assessed by CT-Scan

Secondary Outcomes

  • Residual transvalvular gradients(24 months)

Study Sites (15)

Loading locations...

Similar Trials